Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study With a 20-Year Follow-Up

PLoS ONE - United States
doi 10.1371/journal.pone.0019100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus

Biology, Medicine, & Natural Product Chemistry
2018English

Treatment of Epstein�Barr Virus Induced Hemophagocytic Lymphohistiocytosis With Anti-Cd20 Therapy: A Two-Year Follow-Up

International Journal of Case Reports and Images
2018English

Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis

JAMA - Journal of the American Medical Association
Medicine
2001English

A Novel Epstein-Barr Virus Subtype Associated With Nasopharyngeal Carcinoma Found in South China

Cancer Communications
Cancer ResearchOncology
2020English

Nasopharyngeal Carcinoma Risk Prediction via Salivary Detection of Host and Epstein-Barr Virus Genetic Variants

Oncotarget
Oncology
2016English

Detection of Epstein-Barr Virus in Metastatic Lymph Nodes of Patients With Nasopharyngeal Carcinoma and a Primary Unknown Carcinoma

Archives of Otolaryngology–Head & Neck Surgery
2003English

Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing

PLoS ONE
Multidisciplinary
2010English

Therapeutic Implications of Epstein–Barr Virus Infection for the Treatment of Nasopharyngeal Carcinoma

Therapeutics and Clinical Risk Management
2014English

Sequencing-Based Counting and Size Profiling of Plasma Epstein–Barr Virus DNA Enhance Population Screening of Nasopharyngeal Carcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy